Parathyroid hormone-potentiated connective tissue growth factor expression in human renal proximal tubular cells through activating the MAPK and NF-κB signalling pathways

Nephrology Dialysis Transplantation

Volumn 26, Issue 3, 2011, Pages 839-847

  Guo, Yunshan ^a   Yuan, Weijie ^b   Wang, Ling ^b   Shang, Minghua ^b   Peng, Yan ^b  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

chronic kidney disease; NF B; parathyroid hormone (PTH); renal proximal tubular cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CONNECTIVE TISSUE GROWTH FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PARATHYROID HORMONE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KIDNEY TUBULES, PROXIMAL; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PARATHYROID HORMONE; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 79952133216     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq521     Document Type: Article

References (49)

1. Fajtova VT, Sayegh MH, Hickey N et al. Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int 1995;57:329-335
2. Portale AA, Morris RC Jr. Pathogenesis of secondary hyperparathyr-oidism in chronic renal insufficiency. Miner Electrolyte Metab 1991;17:211-220
3. Fisher A, Goh S, Srikusalanukul W et al. Elevated serum PTH is independently associated with poor outcomes in older patients with hip fracture and vitamin D inadequacy. Calcif Tissue Int 2009;85:301-309
4. Takasaki I, Shionoiri H, Yabana M et al. Severe hyperparathyroidism with hypercalcemia associated with chronic renal failure at pre-dialysis stage. Endocr J 1999;46:167-171 (Pubitemid 29197762)
5. Garcia-Ocana A, Gomez-Casero E, Penaranda C et al. Parathyroid hormone-related protein increases DNA synthesis in proximal tubule cells by cyclic AMP-and protein kinase C-dependent pathways. Life Sci 1998;62:2267-2273 (Pubitemid 28273155)
6. Jobin JR, Bonjour JP. Compensatory renal growth: modulation by calcium, PTH and 1, 25 (OH) 2D3. Kidney Int 1986;29:1124-1130 (Pubitemid 16094223)
7. Chen C, Koh AJ, Datta NS et al. Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J Biol Chem 2004;279:29121-29129 (Pubitemid 38915784)
8. Fujita T, Meguro T, Fukuyama R et al. New signaling pathway for parathyroid hormone and cyclic AMP actionon extracellular-regulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMP. J Biol Chem 2002;277:22191-22200 (Pubitemid 34967184)
9. Qin L, Li X, Ko JK et al. Parathyroid hormone uses multiple mechanisms to arrest the cell cycle progression of osteoblastic cells from G1 to S phase. J Biol Chem 2005;280:3104-3111 (Pubitemid 40189421)
10. Syme CA, Friedman PA, Bisello A. Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling. J Biol Chem 2005;280:11281-11288 (Pubitemid 40418434)
11. Rashid G, Bernheim J, Green J et al. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 2007;292: F1215-F1218 (Pubitemid 46572440)
12. Grey A, Mitnick MA, Shapses S et al. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperpara-thyroidism and correlate with markers of bone resorption-a clinical research center study. J Clin Endocrinol Metab 1996;81:3450-3454 (Pubitemid 26339897)
13. Buxton EC, Yao W, Lane NE. Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34). J Clin Endocrinol Metab 2004;89:3332-3336 (Pubitemid 38951900)
14. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001;107:7-11 (Pubitemid 32047405)
15. Becker GJ, Hewitson TD. The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hypertens 2000;9:133-138 (Pubitemid 30131443)
16. Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 2004;363:62-64 (Pubitemid 38076928)
17. Ruiz-Ortega M, Ruperez M, Esteban V et al. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 2006;21:16-20 (Pubitemid 43057101)
18. Esteban V, Lorenzo O, Ruperez M et al. Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol 2004;15:1514-1529 (Pubitemid 38679676)
19. Ruperez M, Lorenzo O, Blanco-Colio LM et al. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 2003;108:1499-1505 (Pubitemid 37176458)
20. Blom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 2002;21:473-482 (Pubitemid 35248272)
21. Stommel JM, Wahl GM. Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. EMBO J 2004;23:1547-1556 (Pubitemid 38579515)
22. Cui B, Johnson SP, Bullock N et al. Bifunctional DNA alkylator 1, 3-Bis (2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway. Mol Pharmacol 2009;75:1356-1363
23. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983;11:1475-1489
24. Schild-Poulter C, Matheos D, Novac O et al. Differential DNA binding of Ku antigen determines its involvement in DNA replication. DNA Cell Biol 2003;22:65-78 (Pubitemid 36408137)
25. Secker GA, Shortt AJ, Sampson E et al. TGFbeta stimulated re-epithelialisation is regulated by CTGF and Ras/MEK/ERK signalling. Exp Cell Res 2008;314:131-142 (Pubitemid 350180781)
26. Muntner P, Jones TM, Hyre AD et al. Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate. Clin J Am Soc Nephrol 2009;4:186-194
27. Healy E, Brady HR. Role of tubule epithelial cells in the pathogenesis of tubulointerstitial fibrosis induced by glomerular disease. Curr Opin Nephrol Hypertens 1998;7:525-530 (Pubitemid 28475291)
28. Lam S, van der Geest RN, Verhagen NA et al. Connective tissue growth factor and igf-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes 2003;52:2975-2983 (Pubitemid 37466868)
29. Liu BC, Chen Q, Luo DD et al. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats. Acta Pharmacol Sin 2003;24:67-73 (Pubitemid 36090779)
30. Makino H, Mukoyama M, Sugawara A et al. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment. Clin Exp Nephrol 2003;7:33-40 (Pubitemid 36460539)
31. Riser BL, Denichilo M, Cortes P et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000;11:25-38 (Pubitemid 30020423)
32. Twigg SM, Joly AH, Chen MM et al. Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts. Endocrinology 2002;143:1260-1269 (Pubitemid 34274355)
33. Wahab NA, Yevdokimova N, Weston BS et al. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J 2001;359:77-87 (Pubitemid 32939209)
34. Okada H, Kikuta T, Inoue T et al. Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner. Am J Pathol 2006;168:737-747 (Pubitemid 43327726)
35. Wang JF, Olson ME, Ma L et al. Connective tissue growth factor siRNA modulates mRNA levels for a subset of molecules in normal and TGF-beta 1-stimulated porcine skin fibroblasts. Wound Repair Regen 2004;12:205-216 (Pubitemid 38520687)
36. Yokoi H, Mukoyama M, Nagae T et al. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointersti-tial fibrosis. J Am Soc Nephrol 2004;15:1430-1440 (Pubitemid 38679668)
37. Verheijen MH, Defize LH. Parathyroid hormone activates mitogen-activated protein kinase via a cAMP-mediated pathway independent of Ras. J Biol Chem 1997;272:3423-3429 (Pubitemid 27066840)
38. Black sa Jr., Palamakumbura AH, Stan M et al. Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase. J Biol Chem 2007;282:15416-15429 (Pubitemid 47093284)
39. Leask A, Holmes A, Black CM et al. Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 2003;278:13008-13015 (Pubitemid 36800068)
40. Lai LP, Mitchell J. Parathyroid hormone inhibits phosphorylation of mitogen-activated protein kinase (MAPK) ERK1/2 through inhibition of c-Raf and activation of MKP-1 in osteoblastic cells. Cell Biochem Funct 2009;27:269-275
41. Verheijen MH, Defize LH. Parathyroid hormone inhibits mitogen-activated protein kinase activation in osteosarcoma cells via a protein kinase A-dependent pathway. Endocrinology 1995;136:3331-3337
42. Ali NN, Gilston V, Winyard PG. Activation of NF-kappaB in human osteoblasts by stimulators of bone resorption. FEBS Lett 1999;460:315-320 (Pubitemid 29495961)
43. Wang AY, Woo J, Wang M et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 2001;12:1927-1936 (Pubitemid 32801369)
44. Aga M, Watters JJ, Pfeiffer ZA et al. Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-kappa B signaling pathways in murine RAW 264.7 macrophages. Am J Physiol Cell Physiol 2004;286: C923-C930 (Pubitemid 38543821)
45. Fu M, Zhang J, Zhu X et al. Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced connective tissue growth factor expression in human aortic smooth muscle cells by interfering with Smad3. J Biol Chem 2001;276:45888-45894
46. Kulkarni NH, Halladay DL, Miles RR et al. Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem 2005;95:1178-1190 (Pubitemid 41420125)
47. Selvamurugan N, Pulumati MR, Tyson DR et al. Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor 1. J Biol Chem 2000;275:5037-5042 (Pubitemid 30108902)
48. Bourgier C, Haydont V, Milliat F et al. Inhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expression. Gut 2005;54:336-343 (Pubitemid 40299087)
49. Tran CM, Markova D, Smith HE et al. Regulation of CCN2/CTGF expression in the nucleus pulposus of the intervertebral disc: role of smad and AP1 signaling. Arthritis Rheum 2010;62:1983-1992